Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age. - Ferguson, Murdo; Schwarz, Tino F; Núñez, Sebastián A; Rodríguez-García, Juan; Mital, Marek; Zala, Carlos; Schmitt, Bernhard; Toursarkissian, Nicole; Mazarro, Dolores Ochoa; Großkopf, Josef; Voors-Pette, Christine; Mehta, Hemalini; et al. (Clinical Infectious Diseases, 2024)